tiprankstipranks
Advertisement
Advertisement
United Therapeutics price target lowered to $515 from $516 at Morgan Stanley
PremiumThe FlyUnited Therapeutics price target lowered to $515 from $516 at Morgan Stanley
21d ago
United Therapeutics price target lowered to $677 from $704 at RBC Capital
Premium
The Fly
United Therapeutics price target lowered to $677 from $704 at RBC Capital
21d ago
United Therapeutics Balances Tyvaso Woes With Pipeline Wins
Premium
Company Announcements
United Therapeutics Balances Tyvaso Woes With Pipeline Wins
21d ago
United Therapeutics price target raised to $687 from $685 at JPMorgan
PremiumThe FlyUnited Therapeutics price target raised to $687 from $685 at JPMorgan
1M ago
United Therapeutics Adds Victor Dzau to Board
Premium
Company Announcements
United Therapeutics Adds Victor Dzau to Board
1M ago
United Therapeutics price target lowered to $613 from $620 at BofA
Premium
The Fly
United Therapeutics price target lowered to $613 from $620 at BofA
2M ago
PHINDER Trial Update: How Earlier Pulmonary Hypertension Screening Could Shape United Therapeutics’ Market
PremiumCompany AnnouncementsPHINDER Trial Update: How Earlier Pulmonary Hypertension Screening Could Shape United Therapeutics’ Market
3M ago
United Therapeutics Advances High-Risk, High-Reward Xenokidney Trial for ESRD
Premium
Company Announcements
United Therapeutics Advances High-Risk, High-Reward Xenokidney Trial for ESRD
3M ago
United Therapeutics says TETON-1 study published in NEJM
Premium
The Fly
United Therapeutics says TETON-1 study published in NEJM
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100